ferrous sulfate has been researched along with zinc protoporphyrin ix in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| LaGrone, DH; Siegel, RM | 1 |
| Juul, SE; Strandjord, TP; Woodrum, DE; Zerzan, JC | 1 |
| Juul, SE; McPherson, RJ; Miller, SM | 1 |
| Hao, L; Lehmann, A; Liu, L; Neuhaus, P; Nussler, A; Nussler, N; Song, F; Yao, P; Zhao, J | 1 |
| Miller, SM | 1 |
| Qiao, C; Wang, L; Xiao, SH; Xue, J | 1 |
2 trial(s) available for ferrous sulfate and zinc protoporphyrin ix
| Article | Year |
|---|---|
Iron sulfate supplementation decreases zinc protoporphyrin to heme ratio in premature infants.
Topics: Age Factors; Dietary Supplements; Dose-Response Relationship, Drug; Female; Ferritins; Ferrous Compounds; Heme; Humans; Infant; Infant, Newborn; Infant, Premature; Iron; Isoprostanes; Male; Pilot Projects; Prospective Studies; Protoporphyrins; Reticulocytes; Treatment Outcome | 2006 |
Iron supplementation in premature infants using the zinc protoporphyrin to heme ratio: short- and long-term outcomes.
Topics: Anemia, Iron-Deficiency; Dietary Supplements; Female; Ferrous Compounds; Follow-Up Studies; Heme; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Prospective Studies; Protoporphyrins; Time Factors; Treatment Outcome | 2013 |
4 other study(ies) available for ferrous sulfate and zinc protoporphyrin ix
| Article | Year |
|---|---|
The use of zinc protoporphyrin in screening young children for iron deficiency.
Topics: Anemia, Iron-Deficiency; Chi-Square Distribution; Child, Preschool; Ferrous Compounds; Fluorometry; Hematocrit; Humans; Infant; Iron Deficiencies; Mass Screening; Mississippi; Protoporphyrins; Sensitivity and Specificity | 1994 |
Zinc protoporphyrin/heme as an indicator of iron status in NICU patients.
Topics: Biomarkers; Blood Cell Count; Erythrocyte Transfusion; Erythropoietin; Ferrous Compounds; Gestational Age; Heme; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Iron Deficiencies; Protoporphyrins; Recombinant Proteins; Reference Values; Risk Factors | 2003 |
The protective role of HO-1 and its generated products (CO, bilirubin, and Fe) in ethanol-induced human hepatocyte damage.
Topics: Allyl Compounds; Bilirubin; Carbon Monoxide; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; Deferoxamine; Disulfides; Enzyme Inhibitors; Ethanol; Ferrous Compounds; Glutathione; Heme Oxygenase-1; Hemoglobins; Hepatocytes; Humans; Iron; L-Lactate Dehydrogenase; Liver Diseases, Alcoholic; Malondialdehyde; Organometallic Compounds; Protoporphyrins; Quercetin; Transaminases | 2009 |
Mefloquine in combination with hemin causes severe damage to adult Schistosoma japonicum in vitro.
Topics: 2,2'-Dipyridyl; Animals; Anthelmintics; Ascorbic Acid; Cysteine; Deferiprone; Deferoxamine; Drug Synergism; Drug Therapy, Combination; Ferric Compounds; Ferrous Compounds; Glutathione; Hemin; Inhibitory Concentration 50; Iron Chelating Agents; Mefloquine; Protoporphyrins; Pyridones; Schistosoma japonicum | 2014 |